Why Financial Agency Group
The difference between attempting a U.S. listing and completing one.
Plenty of firms will sell you documents. We deliver something rarer: an honest assessment, a coherent plan, and a coordinated team that carries you from private company to public issuer.
Six Reasons
What sets our advisory apart
01 · Cross-border is our specialty, not a sideline
We work exclusively at the intersection of emerging-market companies and U.S. capital markets. We understand Indian promoter structures, Gulf free-zone entities, and family shareholding patterns — and how U.S. regulators and investors will read each of them.
02 · A vetted U.S. ecosystem, pre-assembled
U.S. securities attorneys, PCAOB-registered auditors, FINRA-registered broker-dealers, transfer agents, EDGAR filing agents, market makers, and IR professionals — relationships we have already built, so you don't spend a year building them.
03 · Milestone-based, transparent engagement
Every engagement is divided into phases with defined deliverables. You see progress in documents filed and approvals achieved — not in hours billed.
04 · Candor as a policy
If your company is not ready, we say so — and we tell you precisely what must change, whether that takes six months or three years. Our reputation depends on the quality of the companies we bring to market.
05 · Pathway-neutral advice
Regulation A+, Form F-1, OTC quotation, private placement first, or waiting — we advise on the pathway that fits your company, not the one that fits a product we want to sell.
06 · Public-company thinking from day one
We prepare you not just for a listing date, but for the years after it: periodic reporting, investor communications, governance cadence, and the discipline that keeps public companies credible.
Compare
The FAG model versus the fragmented approach
| Dimension | Fragmented approach | With Financial Agency Group |
|---|---|---|
| Coordination | Founder personally manages 6–8 unrelated U.S. vendors | One advisory partner coordinates all professionals to a single plan |
| Sequencing | Work performed out of order; rework and duplicated cost | Milestone sequence designed around regulatory dependencies |
| Cost visibility | Open-ended retainers; surprises at every stage | Phase-based structure with costs understood in advance |
| Readiness | Weaknesses discovered by the regulator or the market | Weaknesses identified and resolved before filing |
| After the listing | Reporting obligations discovered late; compliance risk | Reporting calendar and IR foundations set before debut |
The first step costs nothing but a conversation.
Tell us about your company. We'll tell you, candidly, where you stand.